1. Home
  2. TRAK vs STXS Comparison

TRAK vs STXS Comparison

Compare TRAK & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TRAK

ReposiTrak Inc.

N/A

Current Price

$8.22

Market Cap

157.2M

Sector

Technology

ML Signal

N/A

Logo Stereotaxis Inc.

STXS

Stereotaxis Inc.

N/A

Current Price

$1.25

Market Cap

139.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TRAK
STXS
Founded
1990
1990
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
157.2M
139.3M
IPO Year
1996
2004

Fundamental Metrics

Financial Performance
Metric
TRAK
STXS
Price
$8.22
$1.25
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
★ $4.00
AVG Volume (30 Days)
73.3K
★ 472.7K
Earning Date
05-14-2026
05-12-2026
Dividend Yield
★ 0.90%
N/A
EPS Growth
★ 20.69
16.67
EPS
★ 0.28
N/A
Revenue
$21,007,076.00
★ $29,346,617.00
Revenue This Year
$6.61
$28.22
Revenue Next Year
$10.04
$30.47
P/E Ratio
$29.29
★ N/A
Revenue Growth
★ 4.84
N/A
52 Week Low
$6.94
$1.24
52 Week High
$16.11
$3.59

Technical Indicators

Market Signals
Indicator
TRAK
STXS
Relative Strength Index (RSI) 51.27 39.55
Support Level $8.11 N/A
Resistance Level $9.06 $1.96
Average True Range (ATR) 0.28 0.06
MACD 0.03 -0.00
Stochastic Oscillator 64.25 13.33

Price Performance

Historical Comparison
TRAK
STXS

About TRAK ReposiTrak Inc.

ReposiTrak Inc is a software-as-a-service (SaaS) company based in Murray, Utah, specializing in supply chain management solutions for retailers, suppliers, and wholesalers, prominently in the food industry. The company offers three main product suites: ReposiTrak Compliance Management, ReposiTrak Traceability Network, and ReposiTrak Supply Chain Solutions. These platforms help customers comply with food safety regulations, manage supplier compliance documentation, trace products through the supply chain, and optimize supply chain operations. The company derives revenue from five sources: (i) subscription fees, (ii) transaction-based fees, (iii) professional services fees, (iv) license fees, and (v) hosting and maintenance fees.

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems, Disposables, Royalty, and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

Share on Social Networks: